Paradigm Capital Management Inc’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-581,900
| Closed | -$1.58M | – | 172 |
|
|
2016
Q3 | $1.58M | Buy |
581,900
+95,100
| +20% | +$259K | 0.17% | 85 |
|
|
2016
Q2 | $1.39M | Buy |
486,800
+146,600
| +43% | +$419K | 0.17% | 96 |
|
|
2016
Q1 | $1.03M | Buy |
340,200
+113,200
| +50% | +$342K | 0.12% | 115 |
|
|
2015
Q4 | $788K | Buy |
227,000
+42,311
| +23% | +$147K | 0.09% | 130 |
|
|
2015
Q3 | $698K | Buy |
184,689
+50,089
| +37% | +$189K | 0.09% | 137 |
|
|
2015
Q2 | $767K | Buy |
+134,600
| New | +$767K | 0.08% | 140 |
|